Development of a database system for drug discovery by employing grid technology

Now that the human genome project has been completed and the human genes have been identified, genome-based drug discovery is starting to play a major role. It involves the process of target and lead identifications; identifying proteins (or drug targets) causing the disease, and identifying the lead compounds that would counteract them. We have developed a system for accelerating drug discovery, especially focusing on the lead identification. The system is based on Globus Toolkit3/OGSA-DAI and is accessible through the OGSA grid data service. In this system, we have designed meta-databases for integrating information on disease, proteins (drug targets) and ligands (lead compounds). Using this system, one could easily screen a large library of compounds for ligands of a given protein, just by specifying the protein sequence. The effectiveness of our system is demonstrated by measuring the performance of the lead identification of several target proteins, such as nuclear receptors.

[1]  Ovanes Mekenyan,et al.  Quantitative structure‐activity relationship models for prediction of estrogen receptor binding affinity of structurally diverse chemicals , 2003, Environmental toxicology and chemistry.

[2]  Nicolas Le Novère,et al.  LGICdb: the ligand-gated ion channel database , 2001, Nucleic Acids Res..

[3]  Philip E. Bourne,et al.  The distribution and query systems of the RCSB Protein Data Bank , 2004, Nucleic Acids Res..

[4]  Ruedi Stoop,et al.  An Ontology for Pharmaceutical Ligands and Its Application for in Silico Screening and Library Design , 2002, J. Chem. Inf. Comput. Sci..

[5]  Tipton Kf,et al.  Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Enzyme nomenclature. Recommendations 1992. Supplement: corrections and additions. , 1994 .

[6]  Robert S. Ledley,et al.  The Protein Information Resource , 2003, Nucleic Acids Res..

[7]  P. Willett,et al.  A Comparison of Some Measures for the Determination of Inter‐Molecular Structural Similarity Measures of Inter‐Molecular Structural Similarity , 1986 .

[8]  Maria Jesus Martin,et al.  The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..

[9]  Pierre Acklin,et al.  Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..

[10]  E. Webb.  Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes. , 1992 .

[11]  Steven Tuecke,et al.  The Physiology of the Grid An Open Grid Services Architecture for Distributed Systems Integration , 2002 .

[12]  S Date,et al.  An OGSA-based Integration of Life-scientific Resources for Drug Discovery , 2005, Methods of Information in Medicine.